Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

51,107 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma.
Zhao X, Wang MY, Jiang H, Lwin T, Park PM, Gao J, Meads MB, Ren Y, Li T, Sun J, Fahmi NA, Singh S, Sehgal L, Wang X, Silva AS, Sotomayor EM, Shain KH, Cleveland JL, Wang M, Zhang W, Qi J, Shah BD, Tao J. Zhao X, et al. Cell Rep. 2021 Mar 16;34(11):108870. doi: 10.1016/j.celrep.2021.108870. Cell Rep. 2021. PMID: 33730585 Free PMC article.
Coordinated silencing of MYC-mediated miR-29 by HDAC3 and EZH2 as a therapeutic target of histone modification in aggressive B-Cell lymphomas.
Zhang X, Zhao X, Fiskus W, Lin J, Lwin T, Rao R, Zhang Y, Chan JC, Fu K, Marquez VE, Chen-Kiang S, Moscinski LC, Seto E, Dalton WS, Wright KL, Sotomayor E, Bhalla K, Tao J. Zhang X, et al. Among authors: zhao x. Cancer Cell. 2012 Oct 16;22(4):506-523. doi: 10.1016/j.ccr.2012.09.003. Cancer Cell. 2012. Retraction in: Cancer Cell. 2023 Jun 12;41(6):1198. doi: 10.1016/j.ccell.2023.05.003. PMID: 23079660 Free PMC article. Retracted.
Epigenetics, c-Myc and aggressive B-cell lymphomas.
Zhang Y, Zhao X, Tao J. Zhang Y, et al. Among authors: zhao x. Oncotarget. 2012 Nov;3(11):1264-5. doi: 10.18632/oncotarget.748. Oncotarget. 2012. PMID: 23175515 Free PMC article. No abstract available.
MYC and MiR: vicious circle.
Zhao X, Zhang X, Tao J. Zhao X, et al. Oncotarget. 2013 Dec;4(12):2168-9. doi: 10.18632/oncotarget.1602. Oncotarget. 2013. PMID: 24318653 Free PMC article. No abstract available.
Unification of de novo and acquired ibrutinib resistance in mantle cell lymphoma.
Zhao X, Lwin T, Silva A, Shah B, Tao J, Fang B, Zhang L, Fu K, Bi C, Li J, Jiang H, Meads MB, Jacobson T, Silva M, Distler A, Darville L, Zhang L, Han Y, Rebatchouk D, Di Liberto M, Moscinski LC, Koomen JM, Dalton WS, Shain KH, Wang M, Sotomayor E, Tao J. Zhao X, et al. Nat Commun. 2017 Apr 18;8:14920. doi: 10.1038/ncomms14920. Nat Commun. 2017. PMID: 28416797 Free PMC article.
BRD4: epigenetic origin and target of CTCL.
Zhao X, Tao J. Zhao X, et al. Blood. 2018 Feb 15;131(7):712-713. doi: 10.1182/blood-2017-12-820266. Blood. 2018. PMID: 29449301 Free article. No abstract available.
51,107 results
You have reached the last available page of results. Please see the User Guide for more information.